Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors
2023 · Breast Cancer Research · 13 citations
https://doi.org/10.1186/s13058-023-01648-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Gijs Louwerens is an academic researcher.
Click to start Chat